These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 8434422)
21. Incrusted cystitis after intravesical mitomycin C treatment. Llopis M; Moreno J; Botella R; Algado M Acta Urol Belg; 1993 Sep; 61(3):21-3. PubMed ID: 8256682 [TBL] [Abstract][Full Text] [Related]
22. Is it possible to stop follow-up of patients with primary T1G3 urothelial carcinoma of the bladder managed with intravesical bacille Calmette-Guérin immunotherapy? Golabek T; Palou J; Rodríguez O; Gaya JM; Breda A; Villavicencio H World J Urol; 2017 Feb; 35(2):237-243. PubMed ID: 27277599 [TBL] [Abstract][Full Text] [Related]
23. Nephrogenic adenoma in patients with transitional cell carcinoma of the bladder receiving intravesical thiotepa. Wood DP; Streem SB; Levin HS J Urol; 1988 Jan; 139(1):130-1. PubMed ID: 3121867 [TBL] [Abstract][Full Text] [Related]
24. Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder. Karam JA; Lotan Y; Ashfaq R; Sagalowsky AI; Shariat SF Urology; 2007 Sep; 70(3):482-6. PubMed ID: 17905101 [TBL] [Abstract][Full Text] [Related]
25. Thiotepa effects on urinary cytology in the interpretation of transitional cell cancer. Droller MJ; Erozan YS J Urol; 1985 Oct; 134(4):671-4. PubMed ID: 3928906 [TBL] [Abstract][Full Text] [Related]
26. [Study of the synergy of microwave hyperthermia/intravesical chemotherapy in the prevention of recurrences of superficial tumors of the bladder]. Mauroy B; Bonnal JL; Prevost B; Chive M; Lhotellier V; Sozanski JP; Vanseymortier L; Stefaniak X Prog Urol; 1999 Feb; 9(1):69-80. PubMed ID: 10212955 [TBL] [Abstract][Full Text] [Related]
27. Long-term follow-up of intravesical bacillus Calmette-Guérin treatment for superficial transitional-cell carcinoma of the bladder involving the prostatic urethra. Taylor JH; Davis J; Schellhammer P Clin Genitourin Cancer; 2007 Sep; 5(6):386-9. PubMed ID: 17956711 [TBL] [Abstract][Full Text] [Related]
28. [Calcified bladder lesions secondary to the instillation of mitomycin C]. Megias Garrigós J; Pelluch Auladell A; Romero Pérez P; Fernandez García J; Gassó Matoses M; Sánchez Marcos M; Mira Llinarés A Arch Esp Urol; 1991 Nov; 44(9):1057-60. PubMed ID: 1807206 [TBL] [Abstract][Full Text] [Related]
29. [Long-term effects on recurrence and mortality in superficial urothelioma of the bladder treated with endovesical chemotherapy]. Ferraris V; Serao A; Buffa G Minerva Urol Nefrol; 1999 Jun; 51(2):95-101. PubMed ID: 10429419 [TBL] [Abstract][Full Text] [Related]
30. Treatment schedule of intravesical chemotherapy with mitomycin C in superficial bladder cancer: short-term courses or maintenance therapy. van der Meijden AP; DeBruyne FM Urology; 1988 Mar; 31(3 Suppl):26-9. PubMed ID: 3126592 [TBL] [Abstract][Full Text] [Related]
34. Cytological and histological changes in the urothelium produced by electromotive drug administration (EMDA) and by the combination of intravescical hyperthermia and chemotherapy (thermochemotherapy). Pierconti F; Straccia P; Emilio S; Bassi PF; De Pascalis I; Marques RC; Volavsek M; Larocca LM; Lopez-Beltran A Pathol Res Pract; 2017 Sep; 213(9):1078-1081. PubMed ID: 28843746 [TBL] [Abstract][Full Text] [Related]
35. Introduction and overview of intravesical therapy for superficial bladder cancer. Soloway MS Urology; 1988 Mar; 31(3 Suppl):5-16. PubMed ID: 3126593 [TBL] [Abstract][Full Text] [Related]
36. Local microwave hyperthermia and intravesical chemotherapy as bladder sparing treatment for select multifocal and unresectable superficial bladder tumors. Colombo R; Da Pozzo LF; Lev A; Salonia A; Rigatti P; Leib Z; Servadio C; Caldarera E; Pavone-Macaluso M J Urol; 1998 Mar; 159(3):783-7. PubMed ID: 9474148 [TBL] [Abstract][Full Text] [Related]
37. Should patients with primary upper urinary tract cancer receive prophylactic intravesical chemotherapy after nephroureterectomy? Wu WJ; Ke HL; Yang YH; Li CC; Chou YH; Huang CH J Urol; 2010 Jan; 183(1):56-61. PubMed ID: 19913833 [TBL] [Abstract][Full Text] [Related]
38. Intravesical therapy comparing BCG, adriamycin, and thiotepa in 200 patients with superficial bladder cancer: a randomized prospective study. Martinez-Pineiro JA; Jimenez León J; Martinez-Pineiro L; Fiter L; Mosteiro JA; Navarro J; García Matres MJ; Cárcamo P Prog Clin Biol Res; 1989; 310():237-52. PubMed ID: 2505269 [TBL] [Abstract][Full Text] [Related]
39. Intravesical mitomycin C combined with hyperthermia for patients with T1G3 transitional cell carcinoma of the bladder. Halachmi S; Moskovitz B; Maffezzini M; Conti G; Verweij F; Kedar D; Sandri SD; Nativ O; Colombo R Urol Oncol; 2011; 29(3):259-64. PubMed ID: 19395285 [TBL] [Abstract][Full Text] [Related]
40. Intravesical thermo-chemotherapy based on conductive heat: a first pharmacokinetic study with mitomycin C in superficial transitional cell carcinoma patients. Milla P; Fiorito C; Soria F; Arpicco S; Cattel L; Gontero P Cancer Chemother Pharmacol; 2014 Mar; 73(3):503-9. PubMed ID: 24442034 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]